A Novel Toll-Like Receptor 9 Agonist Cooperates With Trastuzumab in Trastuzumab-Resistant Breast Tumors Through Multiple Mechanisms of Action

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1599
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Toll-Like Receptor 9 Expression in Breast and Ovarian Cancer Is Associated With Poorly Differentiated Tumors

Cancer Science
Cancer ResearchMedicineOncology
2010English

Toll Like Receptor-9 Mediated Invasion in Breast Cancer

2012English

Toll Like Receptor-9 Mediated Invasion in Breast Cancer

2012English

Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer

International Journal of Breast Cancer
Cancer ResearchOncologyPharmacology
2012English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

Anthocyanins Inhibit Trastuzumab-Resistant Breast Cancer In�vitro and In�vivo

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Trastuzumab-Resistance and Breast Cancer

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy